Diosmin
- Level
- Commodity
- Parent
- 50501500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 50501521This classification denotes a bioflavonoid with the molecular formula C28H32O15, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 7QM776WJ5N, chemically known as 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)- but more generally known as diosmin, which bears U.S. National Institutes of Health Compound Identifier 5281613. European Medicines Agency schedules Diosmin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07198MIG. The term DIOSMIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules diosmin in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. DIOSMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
Same parent
Under 50501500 · 25Activities that produce or sell this
KBLI · 8Inherited from family 50500000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.